Abstract
Background: Acute myeloid leukemia (AML) is the commonest acute leukemia in adults. Allogeneic stem celltransplantation (ASCT) is a curative option for a subset of these patients.Case Presentation: We report the case of a 36 years old female patient who presented in April 2014 with pancytopenia.Investigations revealed that she had AML (M6). She achieved complete remission with induction chemotherapy which wasfollowed by four cycles of consolidation chemotherapy until a human leukocyte antigen-matched donor was available. Sheunderwent ASCT in January 2015. After 14 months, in March 2016, she presented with left breast and rightparapharyngeal masses. Histopathological examination of the excised mass showed infiltration with myeloid cells and thebone marrow was normocellular without leukemic infiltration. She received radiotherapy to the affected breast and thecervical region followed by chemotherapy with good response.Conclusion: AML relapse following ASCT may be in the form of isolated Extramedullary disease. Further research isneeded to optimize the management of these cases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
